Valneva SE (VALN)
USD 3.71
(0.59%)
USD 3.71
(0.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 82.73 Million EUR | 160.37% |
| 2022 | -137.04 Million EUR | 40.92% |
| 2021 | -231.98 Million EUR | -134.47% |
| 2020 | -98.94 Million EUR | -576.21% |
| 2019 | 20.77 Million EUR | 206.63% |
| 2018 | -19.48 Million EUR | -151.34% |
| 2017 | 37.95 Million EUR | -19.66% |
| 2016 | 47.23 Million EUR | -21.73% |
| 2015 | 60.34 Million EUR | 36.23% |
| 2014 | 44.29 Million EUR | 27.39% |
| 2013 | 34.77 Million EUR | 491.18% |
| 2012 | 5.88 Million EUR | 289.07% |
| 2011 | -3.11 Million EUR | 88.87% |
| 2010 | -27.95 Million EUR | -62.71% |
| 2009 | -17.17 Million EUR | -21.96% |
| 2008 | -14.08 Million EUR | -45.1% |
| 2007 | -9.7 Million EUR | -401.18% |
| 2006 | 3.22 Million EUR | 126.81% |
| 2005 | 1.42 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 78.22 Million EUR | 123.29% |
| 2024 Q1 | 35.03 Million EUR | -57.66% |
| 2023 Q4 | 82.73 Million EUR | 255.85% |
| 2023 Q1 | -101.75 Million USD | 25.75% |
| 2023 FY | 82.73 Million EUR | 160.37% |
| 2023 Q2 | -55.17 Million EUR | 45.77% |
| 2023 Q3 | 23.25 Million EUR | 142.14% |
| 2022 Q2 | -202.65 Million EUR | -3.53% |
| 2022 Q3 | -99.42 Million EUR | 50.94% |
| 2022 Q4 | -137.04 Million EUR | -37.84% |
| 2022 FY | -137.04 Million EUR | 40.92% |
| 2022 Q1 | -195.74 Million EUR | 15.62% |
| 2021 Q4 | -231.98 Million EUR | 0.0% |
| 2021 FY | -231.98 Million EUR | -134.47% |
| 2021 Q2 | -218.23 Million EUR | -68.0% |
| 2021 Q1 | -129.9 Million EUR | -31.29% |
| 2020 Q4 | -98.94 Million EUR | -120.31% |
| 2020 FY | -98.94 Million EUR | -576.21% |
| 2020 Q1 | 18.45 Million EUR | -11.17% |
| 2020 Q2 | -87.09 Million EUR | -571.9% |
| 2020 Q3 | -44.91 Million EUR | 48.44% |
| 2019 Q2 | 3.77 Million EUR | -55.3% |
| 2019 FY | 20.77 Million EUR | 206.63% |
| 2019 Q1 | 8.44 Million EUR | 143.32% |
| 2019 Q4 | 20.77 Million EUR | 26.43% |
| 2019 Q3 | 16.43 Million EUR | 335.57% |
| 2018 Q4 | -19.48 Million EUR | -171.36% |
| 2018 Q3 | 27.3 Million EUR | -0.16% |
| 2018 Q2 | 27.35 Million EUR | -9.86% |
| 2018 Q1 | 30.34 Million EUR | -20.04% |
| 2018 FY | -19.48 Million EUR | -151.34% |
| 2017 Q3 | 29.35 Million EUR | -2.71% |
| 2017 Q4 | 37.95 Million EUR | 29.3% |
| 2017 FY | 37.95 Million EUR | -19.66% |
| 2017 Q2 | 30.16 Million EUR | 0.1% |
| 2017 Q1 | 30.13 Million EUR | -36.19% |
| 2016 Q2 | 41.81 Million EUR | -14.7% |
| 2016 FY | 47.23 Million EUR | -21.73% |
| 2016 Q4 | 47.23 Million EUR | 18.35% |
| 2016 Q3 | 39.91 Million EUR | -4.55% |
| 2016 Q1 | 49.01 Million EUR | -18.77% |
| 2015 Q2 | 45.58 Million EUR | -12.12% |
| 2015 FY | 60.34 Million EUR | 36.23% |
| 2015 Q3 | 50.73 Million EUR | 11.31% |
| 2015 Q4 | 60.34 Million EUR | 18.95% |
| 2015 Q1 | 51.86 Million EUR | 17.09% |
| 2014 Q2 | 39.32 Million EUR | -9.83% |
| 2014 FY | 44.29 Million EUR | 27.39% |
| 2014 Q4 | 44.29 Million EUR | 7.3% |
| 2014 Q3 | 41.28 Million EUR | 4.97% |
| 2014 Q1 | 43.61 Million EUR | 25.44% |
| 2013 Q1 | 12.05 Million EUR | 104.98% |
| 2013 Q2 | 63.8 Million EUR | 429.19% |
| 2013 Q3 | 33.41 Million EUR | -47.63% |
| 2013 Q4 | 34.77 Million EUR | 4.06% |
| 2013 FY | 34.77 Million EUR | 491.18% |
| 2012 Q2 | 6.09 Million EUR | 0.0% |
| 2012 Q4 | 5.88 Million EUR | 0.0% |
| 2012 FY | 5.88 Million EUR | 289.07% |
| 2011 Q4 | -3.11 Million EUR | 0.0% |
| 2011 Q2 | -22.8 Million EUR | 0.0% |
| 2011 FY | -3.11 Million EUR | 88.87% |
| 2010 Q2 | -1.21 Million EUR | 0.0% |
| 2010 Q4 | -27.95 Million EUR | 0.0% |
| 2010 FY | -27.95 Million EUR | -62.71% |
| 2009 FY | -17.17 Million EUR | -21.96% |
| 2009 Q4 | -17.17 Million EUR | 0.0% |
| 2008 FY | -14.08 Million EUR | -45.1% |
| 2007 FY | -9.7 Million EUR | -401.18% |
| 2006 FY | 3.22 Million EUR | 126.81% |
| 2005 FY | 1.42 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 1206.956% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 49.664% |
| IO Biotech, Inc. | -140.69 Million USD | 158.804% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 371.622% |
| Organovo Holdings, Inc. | -1.5 Million USD | 5590.113% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 3243.298% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 7063.518% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 646.653% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 248.103% |
| Savara Inc. | 153 Thousand USD | -53975.817% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 462.623% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 368.084% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -1087.358% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 2744.152% |
| Soligenix, Inc. | -4.95 Million USD | 1770.895% |
| Aptose Biosciences Inc. | -8.19 Million USD | 1109.609% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -321.156% |
| Century Therapeutics, Inc. | 847 Thousand USD | -9668.123% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -141.438% |
| Precision BioSciences, Inc. | -85.41 Million USD | 196.869% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 141.405% |
| Kura Oncology, Inc. | -20.11 Million USD | 511.254% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 1021.024% |
| Dyadic International, Inc. | -6.37 Million USD | 1397.189% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 302.16% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 153.674% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 2687.926% |
| Autolus Therapeutics plc | -186.59 Million USD | 144.339% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 619.274% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 129.999% |
| GRI Bio, Inc. | -1.79 Million USD | 4711.817% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 348.778% |
| IGM Biosciences, Inc. | -72.6 Million USD | 213.952% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 45.19% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 263.319% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 2967.873% |
| Opthea Limited | 28.15 Million USD | -193.833% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 300.889% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -159.483% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 259.531% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 592.799% |
| Surrozen, Inc. | -32.66 Million USD | 353.294% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 2068.27% |
| Cingulate Inc. | 3.08 Million USD | -2583.896% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -336.367% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 25.376% |
| Acelyrin, Inc. | -216.9 Million USD | 138.144% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 290.452% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 667.585% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 126.117% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 206.824% |
| ADMA Biologics, Inc. | 90.06 Million USD | 8.138% |
| PureTech Health plc | -167.19 Million USD | 149.484% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 1397.006% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 1215.642% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 164.08% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 427.123% |
| Synaptogenix, Inc. | -28.66 Million USD | 388.666% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 8939.316% |
| ChromaDex Corporation | -24.04 Million USD | 444.045% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 1068.445% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 1238.661% |
| Exelixis, Inc. | -73.05 Million USD | 213.259% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -35.064% |
| Better Therapeutics, Inc. | -860 Thousand USD | 9720.465% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 444.547% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 134.278% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 1265.296% |
| Seer, Inc. | -4.24 Million USD | 2051.321% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -6497.767% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 318.197% |
| Gritstone bio, Inc. | 39.49 Million USD | -109.511% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 198.377% |
| Avid Bioservices, Inc. | 169.72 Million USD | 51.254% |
| Insmed Incorporated | 721.62 Million USD | 88.535% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -3062.691% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 2455.138% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -34.168% |
| MediWound Ltd. | -5.32 Million USD | 1654.604% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -128.786% |
| Fortress Biotech, Inc. | 7.66 Million USD | -979.4% |
| OmniAb, Inc. | 9.2 Million USD | -799.011% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 3.763% |
| Zai Lab Limited | -775 Million USD | 110.676% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 75.706% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 142.821% |
| Veracyte, Inc. | -203.82 Million USD | 140.592% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 1011.892% |
| FibroGen, Inc. | 56.76 Million USD | -45.747% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 171.151% |
| ContextLogic Inc. | -232 Million USD | 135.662% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 1085.187% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 3026.551% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 174.849% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 98.198% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -13074.522% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 2576.384% |
| ImmuCell Corporation | 10.99 Million USD | -652.791% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 94.728% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 438.084% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 198.377% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 334.626% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 148.55% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -1353.804% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 189.566% |
| Vaxxinity, Inc. | 10.13 Million USD | -716.581% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 88.763% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 868.383% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 2496.288% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 647.505% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -1890.76% |
| Senti Biosciences, Inc. | 1.74 Million USD | -4654.943% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 11558.328% |
| Apollomics, Inc. | -27.39 Million USD | 402.011% |
| 89bio, Inc. | -289.05 Million USD | 128.623% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -1833.084% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 3670.783% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 303.924% |
| Ardelyx, Inc. | 34.51 Million USD | -139.731% |
| Pluri Inc. | 22.82 Million USD | -262.416% |
| Prothena Corporation plc | -608.34 Million USD | 113.6% |
| Pulmatrix, Inc. | -10.41 Million USD | 894.24% |
| Celularity Inc. | 65.19 Million USD | -26.915% |
| MeiraGTx Holdings plc | -40.3 Million USD | 305.29% |
| Omeros Corporation | 331.17 Million USD | 75.018% |
| Ainos, Inc. | 4.07 Million USD | -1928.873% |
| Humacyte, Inc. | -22.48 Million USD | 467.944% |
| Mesoblast Limited | 55.96 Million USD | -47.841% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 436.667% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 367.745% |
| Blueprint Medicines Corporation | 702.83 Million USD | 88.228% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 143.957% |
| Summit Therapeutics Inc. | 34.67 Million USD | -138.611% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 1464.83% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 306.649% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 174.268% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 238.022% |
| Cytokinetics, Incorporated | 642.37 Million USD | 87.12% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 1520.848% |
| Nutriband Inc. | -251.65 Thousand USD | 32976.495% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 342.492% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 101.371% |
| Evogene Ltd. | -19.63 Million USD | 521.391% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 269.987% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 995.684% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 93.934% |
| BioLineRx Ltd. | 7.33 Million USD | -1027.808% |
| Atai Life Sciences N.V. | -28.55 Million USD | 389.712% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 170.687% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -69.778% |
| MediciNova, Inc. | -50.78 Million USD | 262.919% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 204.988% |
| MiMedx Group, Inc. | -33.9 Million USD | 344.052% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 146.228% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 187.234% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 128.165% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 609.164% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -1712.002% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 135.291% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 187.82% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 186.457% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 311.747% |
| Allakos Inc. | -24.97 Million USD | 431.275% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 661.226% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 161.105% |
| BioAtla, Inc. | -109.01 Million USD | 175.897% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -591.426% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 490.209% |
| Precigen, Inc. | -481 Thousand USD | 17300.832% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 9697.153% |
| XOMA Corporation | -29 Million USD | 385.297% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 599.614% |
| Incyte Corporation | -3.17 Billion USD | 102.606% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 1017.657% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 166.382% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 546.742% |
| CRISPR Therapeutics AG | -150.84 Million USD | 154.848% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 139.746% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 189.191% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 9729.602% |
| UroGen Pharma Ltd. | 4.39 Million USD | -1784.218% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 27.093% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -114871.791% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 471.213% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 144.817% |
| Chimerix, Inc. | -25.51 Million USD | 424.239% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -580.212% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 4300.198% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 240.528% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 482.916% |
| Portage Biotech Inc. | -4.98 Million USD | 1761.032% |
| OncoCyte Corporation | -6.56 Million USD | 1360.643% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -9119.39% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 1087.168% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 1916.121% |
| Purple Biotech Ltd. | -14.13 Million USD | 685.203% |
| NextCure, Inc. | -6.47 Million USD | 1377.382% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 595.658% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 1212.322% |
| Generation Bio Co. | 31.44 Million USD | -163.088% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 122.433% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 48.847% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 1189.205% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -11140.296% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 267.808% |
| Novavax, Inc. | -298.29 Million USD | 127.736% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 2594.343% |
| Curis, Inc. | -23.88 Million USD | 446.364% |
| Daré Bioscience, Inc. | -5.15 Million USD | 1704.06% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 1432.732% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 1005.058% |
| Bicycle Therapeutics plc | -481.46 Million USD | 117.184% |
| BeiGene, Ltd. | -2.25 Billion USD | 103.672% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -570.552% |
| Alector, Inc. | -35.63 Million USD | 332.163% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 144.581% |
| Erasca, Inc. | -37.21 Million USD | 322.313% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 1778.896% |
| Aura Biosciences, Inc. | -21.52 Million USD | 484.372% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -524.941% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 1021.741% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 6524.136% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 575.604% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 78.155% |
| Histogen Inc. | -7.48 Million USD | 1205.062% |
| Fortress Biotech, Inc. | 7.66 Million USD | -979.4% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 147.216% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 200.31% |
| Galecto, Inc. | -21.21 Million USD | 489.97% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 87.038% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 134.137% |
| Molecular Templates, Inc. | 707 Thousand USD | -11602.405% |
| PDS Biotechnology Corporation | -32.7 Million USD | 352.946% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 149.852% |
| Amarin Corporation plc | -191.04 Million USD | 143.308% |
| TG Therapeutics, Inc. | 17.86 Million USD | -363.196% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 819.006% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 356.371% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 340.68% |
| Onconetix, Inc. | 5.33 Million USD | -1451.852% |
| MacroGenics, Inc. | -66.98 Million USD | 223.514% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 207.146% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 263.83% |
| Adagene Inc. | -87.62 Million USD | 194.418% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 222.06% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 225.441% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 270.558% |
| SciSparc Ltd. | -2.06 Million USD | 4106.586% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 789.944% |
| Minerva Neurosciences, Inc. | 41 Million USD | -101.774% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 147.18% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 367.555% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 29.039% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 191.654% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 95.575% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -1100.012% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 1312.249% |
| 2seventy bio, Inc. | 181.71 Million USD | 54.469% |
| Clene Inc. | 3.34 Million USD | -2377.126% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 484.622% |
| GeoVax Labs, Inc. | -6.45 Million USD | 1382.214% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 4096.236% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 571.054% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 66514.61% |
| Absci Corporation | -72.59 Million USD | 213.965% |
| XBiotech Inc. | -200.02 Million USD | 141.363% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 1688.328% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -1727.208% |
| Entera Bio Ltd. | -10.62 Million USD | 878.399% |
| Trevena, Inc. | 2.25 Million USD | -3564.128% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 169.669% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 449.436% |
| INmune Bio, Inc. | -25.41 Million USD | 425.591% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 418.219% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 260.621% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 2917.024% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -1051.19% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 990.474% |
| Jaguar Health, Inc. | 29.39 Million USD | -181.501% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -487.572% |
| NexImmune, Inc. | -3.13 Million USD | 2740.25% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 178.392% |
| Clearmind Medicine Inc. | -3.94 Million USD | 2198.494% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 33882.482% |
| Kronos Bio, Inc. | -36.05 Million USD | 329.478% |
| Innoviva, Inc. | 255.56 Million USD | 67.626% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 78.109% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 405.299% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -779.328% |
| Verastem, Inc. | -37.27 Million USD | 321.943% |
| ProKidney Corp. | -56.23 Million USD | 247.123% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -5574.129% |
| Imunon, Inc. | -4.21 Million USD | 2063.429% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 252.492% |
| Statera Biopharma, Inc. | 14.41 Million USD | -473.902% |
| ImmunityBio, Inc. | 618.22 Million USD | 86.617% |
| Korro Bio, Inc. | -132.94 Million USD | 162.234% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 76.13% |
| Kineta, Inc. | -4.54 Million USD | 1921.978% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 161.707% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 1010.918% |
| GT Biopharma, Inc. | -1.02 Million USD | 8203.428% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 126.124% |
| Celularity Inc. | 65.19 Million USD | -26.915% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 2710.792% |
| CalciMedica, Inc. | -5.53 Million USD | 1596.13% |
| Cibus, Inc. | -8.07 Million USD | 1124.214% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 248.768% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 910.025% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 2056.396% |
| Kodiak Sciences Inc. | -103.87 Million USD | 179.65% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 348.808% |
| Annexon, Inc. | -193.75 Million USD | 142.701% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -229722.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 572.804% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 1484.24% |
| Moderna, Inc. | -2.9 Billion USD | 102.846% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 316.916% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 92.152% |
| Vor Biopharma Inc. | 4.3 Million USD | -1824.093% |
| Eyenovia, Inc. | 1.25 Million USD | -6473.121% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 2097.007% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -207.512% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 200.821% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 149.179% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 2651.218% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 162.94% |
| Immunocore Holdings plc | -358.59 Million USD | 123.072% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 401.242% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -79.288% |
| Alkermes plc | -166.73 Million USD | 149.62% |
| Arcellx, Inc. | -296.95 Million USD | 127.861% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -3609.255% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -366.513% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 210.206% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 499.17% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 367897.288% |
| Moolec Science SA | 117.61 Thousand USD | -70244.171% |
| Biomea Fusion, Inc. | -166.57 Million USD | 149.67% |
| RenovoRx, Inc. | -1.17 Million USD | 7153.367% |
| Geron Corporation | 14.76 Million USD | -460.504% |
| Mereo BioPharma Group plc | -51.46 Million USD | 260.749% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 444.203% |
| Royalty Pharma plc | 5.65 Billion USD | 98.538% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 158.503% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 1283.731% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 447.849% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 1642.759% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 158.79% |
| Humacyte, Inc. | -22.48 Million USD | 467.944% |
| Structure Therapeutics Inc. | -124.33 Million USD | 166.541% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -11140.296% |
| Genelux Corporation | -6.89 Million USD | 1299.246% |
| ESSA Pharma Inc. | -33.62 Million USD | 346.08% |
| aTyr Pharma, Inc. | -7.44 Million USD | 1210.699% |
| Notable Labs, Ltd. | -9.77 Million USD | 946.318% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 109925.577% |
| Mustang Bio, Inc. | -3.73 Million USD | 2314.561% |
| Immunovant, Inc. | -635.22 Million USD | 113.025% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -4998.066% |
| Vericel Corporation | 1.27 Million USD | -6378.935% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 94.008% |
| Akari Therapeutics, Plc | -3.84 Million USD | 2251.782% |
| Acasti Pharma Inc. | -23 Million USD | 459.644% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 2557.095% |
| Vaxcyte, Inc. | -368.22 Million USD | 122.469% |
| Orgenesis Inc. | 21.78 Million USD | -279.802% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 190.195% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 472.148% |
| GH Research PLC | -78.07 Million USD | 205.967% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 545.56% |
| PepGen Inc. | -60.67 Million USD | 236.371% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 460.097% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 2122.11% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 9697.153% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 2068.27% |
| Silo Pharma, Inc. | -3.52 Million USD | 2447.581% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -82827.563% |
| Belite Bio, Inc | -87.27 Million USD | 194.804% |
| Pharming Group N.V. | 109.8 Million USD | 24.651% |
| XOMA Corporation | -29 Million USD | 385.297% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 410.349% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 546.742% |
| Bionomics Limited | 227 Million USD | 63.554% |
| Xencor, Inc. | 29.64 Million USD | -179.099% |
| Replimune Group, Inc. | 1.41 Million USD | -5759.49% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -711.535% |
| Cassava Sciences, Inc. | -121.13 Million USD | 168.3% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 165.447% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 2086.254% |
| Turnstone Biologics Corp. | -14.58 Million USD | 667.307% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -561.306% |
| GeoVax Labs, Inc. | -6.45 Million USD | 1382.214% |
| MEI Pharma, Inc. | -3.7 Million USD | 2333.09% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 225.126% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 367897.288% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 8911.076% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -77952.83% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 448.274% |
| scPharmaceuticals Inc. | -6.54 Million USD | 1364.11% |
| HilleVax, Inc. | -165.48 Million USD | 149.996% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -930.721% |
| Tharimmune, Inc. | -10.93 Million USD | 856.592% |
| Genprex, Inc. | -6.73 Million USD | 1327.969% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -829.096% |
| Immunic, Inc. | -45.34 Million USD | 282.479% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 193.529% |
| Aptorum Group Limited | 1.35 Million USD | -5996.772% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 148.876% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -829.096% |
| OKYO Pharma Limited | -826.84 Thousand USD | 10106.192% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 10761.691% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -6881.941% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -4441.704% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 58.228% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 1574.725% |
| bluebird bio, Inc. | 108.57 Million USD | 23.795% |
| DBV Technologies S.A. | -126.98 Million USD | 165.154% |
| Compugen Ltd. | -12.9 Million USD | 741.166% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 6524.136% |
| Peak Bio, Inc. | 10.34 Million USD | -700.143% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 899.227% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 861.281% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 1316.169% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 386.561% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 29335.336% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 363.734% |
| Benitec Biopharma Inc. | -50.58 Million USD | 263.568% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 179.296% |
| Adicet Bio, Inc. | -138.78 Million USD | 159.614% |
| Prime Medicine, Inc. | -27.94 Million USD | 396.11% |
| Aditxt, Inc. | 18.12 Million USD | -356.578% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -378.852% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 2086.254% |
| Quantum-Si incorporated | -118.55 Million USD | 169.786% |
| GlycoMimetics, Inc. | -40.98 Million USD | 301.872% |
| PolyPid Ltd. | 6.17 Million USD | -1240.94% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -11.624% |
| Invivyd, Inc. | -198.47 Million USD | 141.686% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 3550.657% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -197.686% |
| CorMedix Inc. | -43.05 Million USD | 292.175% |
| Instil Bio, Inc. | 75.35 Million USD | -9.791% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 124.042% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 53.432% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -1554.058% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 216.875% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 3366.325% |
| AbCellera Biologics Inc. | -55.94 Million USD | 247.901% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 173.499% |
| Surrozen, Inc. | -32.66 Million USD | 353.294% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -1450.234% |
| Verona Pharma plc | -220.44 Million USD | 137.532% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 204.303% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 163.495% |
| Evaxion Biotech A/S | 5.28 Million USD | -1464.941% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 163.026% |
| Shattuck Labs, Inc. | -121.42 Million USD | 168.138% |
| AlloVir, Inc. | -62.69 Million USD | 231.972% |
| BioVie Inc. | -17.73 Million USD | 566.582% |
| Codexis, Inc. | -43.27 Million USD | 291.204% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 4899.072% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 7063.518% |
| Agenus Inc. | 274.13 Million USD | 69.819% |
| Virax Biolabs Group Limited | -3.36 Million USD | 2558.763% |
| Lantern Pharma Inc. | -21.7 Million USD | 481.214% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 201.17% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -1710.416% |
| Immix Biopharma, Inc. | -17.5 Million USD | 572.513% |
| Celcuity Inc. | 6.78 Million USD | -1119.664% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 524.157% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 315.464% |
| IN8bio, Inc. | -16.38 Million USD | 604.826% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 4740.269% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 366.383% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 1.032% |
| Liquidia Corporation | -80.17 Million USD | 203.193% |
| Quantum-Si incorporated | -118.55 Million USD | 169.786% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 609.164% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 160.067% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 1511.877% |
| United Therapeutics Corporation | -507.7 Million USD | 116.296% |
| Solid Biosciences Inc. | -47.75 Million USD | 273.269% |
| Immuneering Corporation | -54.94 Million USD | 250.586% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 3366.325% |
| uniQure N.V. | -102.95 Million USD | 180.364% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 348.853% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 3716.12% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -102.037% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 697.113% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 427.771% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 2754.891% |
| Cue Biopharma, Inc. | -33.81 Million USD | 344.644% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 532.584% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 217.029% |
| Zura Bio Limited | -99.8 Million USD | 182.897% |
| Forte Biosciences, Inc. | -11.96 Million USD | 791.715% |
| Elevation Oncology, Inc. | -19.11 Million USD | 532.765% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 2651.218% |
| Immunome, Inc. | -97.02 Million USD | 185.269% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 467.797% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 215.323% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -420.405% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 144.602% |
| Altimmune, Inc. | -134.48 Million USD | 161.52% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -117.64% |
| Rallybio Corporation | -24.1 Million USD | 443.274% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 1991.973% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 162.802% |
| Moolec Science SA | 117.61 Thousand USD | -70244.171% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 2773.906% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 6005.496% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 158.966% |
| NeurAxis, Inc. | 145.7 Thousand USD | -56685.175% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -129.79% |
| Lumos Pharma, Inc. | -28.49 Million USD | 390.373% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 215.323% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 12717.388% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -321.156% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 498.27% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -5574.129% |
| Nutriband Inc. | -251.65 Thousand USD | 32976.495% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 1212.043% |
| argenx SE | -2.02 Billion USD | 104.078% |
| Neurogene Inc. | -131.95 Million USD | 162.7% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -279.245% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 1785.394% |
| CervoMed Inc. | -7.79 Million USD | 1161.692% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 121.935% |
| Sesen Bio, Inc. | -112.55 Million USD | 173.508% |
| AnaptysBio, Inc. | -18.15 Million USD | 555.821% |
| Design Therapeutics, Inc. | -18.15 Million USD | 555.846% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 217.554% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -636.61% |
| Achilles Therapeutics plc | -126.92 Million USD | 165.185% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 3359.89% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 728.168% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 75.68% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -248.582% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 118.49% |
| Palisade Bio, Inc. | -12.06 Million USD | 785.866% |
| Beam Therapeutics Inc. | -262.72 Million USD | 131.492% |
| AEON Biopharma, Inc. | -4.88 Million USD | 1795.41% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 182.852% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 3623.99% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 312.002% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 199.344% |
| Athira Pharma, Inc. | -88.99 Million USD | 192.963% |
| Vaccinex, Inc. | -1.28 Million USD | 6523.602% |
| HCW Biologics Inc. | 2.85 Million USD | -2796.233% |
| XOMA Corporation | -29 Million USD | 385.297% |
| Nektar Therapeutics | 210.24 Million USD | 60.647% |
| Arvinas, Inc. | -313.8 Million USD | 126.366% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -4998.066% |
| Merus N.V. | -192.88 Million USD | 142.894% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -37.928% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 1292.505% |
| Rezolute, Inc. | -68.16 Million USD | 221.371% |
| Clene Inc. | 3.34 Million USD | -2377.126% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 727.406% |
| BeyondSpring Inc. | -13.75 Million USD | 701.498% |
| Synlogic, Inc. | -6.68 Million USD | 1337.636% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -7195.944% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 1078.545% |
| Peak Bio, Inc. | 10.34 Million USD | -700.143% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 200.383% |
| Krystal Biotech, Inc. | -350.23 Million USD | 123.623% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 33.345% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 148.957% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 2720.596% |
| MannKind Corporation | 143.89 Million USD | 42.504% |
| Ikena Oncology, Inc. | -109.15 Million USD | 175.796% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 1192.801% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 349.958% |
| Gossamer Bio, Inc. | 180.35 Million USD | 54.126% |
| CohBar, Inc. | -5.93 Million USD | 1495.039% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 378.123% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -1712.002% |
| Legend Biotech Corporation | -949.39 Million USD | 108.715% |
| Mural Oncology plc | -255.84 Million USD | 132.339% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -156.824% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 1856.364% |
| Disc Medicine, Inc. | -358.28 Million USD | 123.092% |
| Champions Oncology, Inc. | 4.81 Million USD | -1619.368% |
| REGENXBIO Inc. | 54.76 Million USD | -51.066% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 30867.514% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 154.783% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 1018.064% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 202.545% |
| Vaxart, Inc. | -8.24 Million USD | 1103.956% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 264.879% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 165.062% |
| Cellectis S.A. | -43.85 Million USD | 288.658% |
| Longeveron Inc. | -2.9 Million USD | 2945.117% |
| Repare Therapeutics Inc. | -107.85 Million USD | 176.708% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 91.456% |
| Inozyme Pharma, Inc. | 12 Million USD | -589.237% |
| Revolution Medicines, Inc. | -608.2 Million USD | 113.603% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 6826.504% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 131.207% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 155.131% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 628.766% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 11280.541% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 100.865% |
| Denali Therapeutics Inc. | -74.86 Million USD | 210.514% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 789.944% |
| Veru Inc. | 4.77 Million USD | -1630.89% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 835.693% |
| Cingulate Inc. | 3.08 Million USD | -2583.896% |
| Passage Bio, Inc. | 4.58 Million USD | -1704.493% |
| Context Therapeutics Inc. | -14.44 Million USD | 672.574% |
| Exicure, Inc. | 5.84 Million USD | -1314.532% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 135.913% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 309.088% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 113.603% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -427.283% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 240.657% |
| Nuvalent, Inc. | -335.38 Million USD | 124.669% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -4670.457% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 211.082% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 1030.664% |
| OmniAb, Inc. | 9.2 Million USD | -799.011% |
| Anew Medical, Inc. | 1.43 Million USD | -5675.778% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -405.05% |
| Lipocine Inc. | -4.75 Million USD | 1840.128% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 175.332% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -443.208% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 263.319% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -232.38% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 1331.007% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 225.687% |
| Ocugen, Inc. | -32.52 Million USD | 354.408% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 196.682% |
| Q32 Bio Inc. | -37.94 Million USD | 318.025% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 13274.522% |
| Alumis Inc. Common Stock | -13.52 Million USD | 711.546% |
| Equillium, Inc. | -22.39 Million USD | 469.489% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 423.592% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 353.583% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 33472.729% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 38.276% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -2487.117% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -25090.521% |
| Dominari Holdings Inc. | 195 Thousand USD | -42328.718% |
| Edesa Biotech, Inc. | -5.26 Million USD | 1670.864% |
| vTv Therapeutics Inc. | -8.91 Million USD | 1027.846% |
| Bio-Techne Corporation | 267.74 Million USD | 69.099% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 610.432% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 170.059% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 1084.601% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 753.988% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 133.753% |
| Nkarta, Inc. | 57.29 Million USD | -44.393% |
| BioCardia, Inc. | 212 Thousand USD | -38926.415% |
| Iterum Therapeutics plc | 13.43 Million USD | -515.687% |